CRBU vs LNC · rev $3.9M vs P/E 4.9, rev $9.85B
Caribou Biosciences Inc (CRBU) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
CRBU currently screens at market cap $190.4M. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the CRBU and LNC stock pages for the full models.
Not investment advice.